Hepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrence.

Pazgan-Simon, Monika; Simon, Krzysztof A; Jarowicz, Ewa; Rotter, Katarzyna; Szymanek-Pasternak, Anna; Zuwala-Jagiello, Jolanta

Pazgan-Simon, Monika; Simon, Krzysztof A; Jarowicz, Ewa; Rotter, Katarzyna; Szymanek-Pasternak, Anna; Zuwala-Jagiello, Jolanta.

Afiliación

Pazgan-Simon M; Department of Infectious Disease 1, Regional Specialistic Hospital, Wroclaw, Poland.
Simon KA; Department of Infectious Disease and Hepatology, Wroclaw Medical University, Wroclaw, Poland.
Jarowicz E; Department of Infectious Disease 2, Regional Specialistic Hospital, Wroclaw, Poland.
Rotter K; Department of Infectious Disease 1, Regional Specialistic Hospital, Wroclaw, Poland.
Szymanek-Pasternak A; Department of Infectious Disease and Hepatology, Wroclaw Medical University, Wroclaw, Poland.
Zuwala-Jagiello J; Department of Pharmacutical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.

Clin Exp Hepatol ; 4(3): 210-216, 2018 Sep.

Article en En | MEDLINE | ID: mdl-30324148

Palabras clave

HBV treatment; HCC; HCC treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Clin Exp Hepatol Año: 2018 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google